Molecular Templates (MTEM) Peer Comparison

$0.00

$0.00 (-96.15%)

As on 20-May-2025 09:30EDT

Market cap

$0 Mln

Revenue (TTM)

$25 Mln

P/E Ratio

--

P/B Ratio

0

Div. Yield

0 %

Edit

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Market cap ($ Mln)	--	266	4
Revenue ($ Mln)	25	48	0
Net Profit ($ Mln)	-7.32	-4.09	-12.39
Net Margin (%)	-28.74	-8.46	-10,151.64
RoE (%)	-129.29	-1.85	-352.55
Price to Earnings	--	--	--
Price-To-Book	0.00	1.24	9.89

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement ($ Mln)

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Operating Revenue	25.47	100.39	0.12
Cost of Revenue	9.34	16.92	0.15
Gross Profit	50.40	83.47	0.08
Operating Expenses	41.51	321.08	12.54
Operating Profit (EBIT)	-8.58	-237.61	-12.56
Other Income	0.00	6.06	0.00
Profit before Tax	-7.33	-217.57	-12.38
Provision for Tax	-0.41	-0.01	-2.41
Profit after Tax (Net Income)	-7.32	-217.57	-12.39
Minority Interest	0.00	--	0.00
Consolidated Profit	0.00	-254.15	0.00

Liabilities ($ Mln)

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Shareholder's Funds	7.11	255.30	0.36
Minority Interest	0.00	--	0.00
Non-Current Liabilities	11.91	250.35	0.54
Current Liabilities	7.68	59.78	2.94
Total Liabilities	35.38	565.43	20.31

Assets ($ Mln)

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Non-Current Assets	14.68	327.66	1.74
Current Assets	12.02	237.77	2.10
Total Assets	35.38	565.43	20.31
Total Debt*	11.03	256.67	1.06
Net Current Assets	4.34	177.99	-0.84

Cashflow ($ Mln)

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Cash From Operating Activities	-41.82	-166.86	-12.41
Cash Flow from Investing Activities	--	11.70	-0.97
Cash from Financing Activities	-9.12	127.39	0.00
Net Cash Inflow / Outflow	--	-59.21	--

Ratios

Profitability Ratios

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
ROCE (%)	-31.31	-39.83	-69.70
ROE (%)	-129.29	-76.91	-352.55
ROA (%)	-15.12	-35.61	-142.67
EBIT Margin (%)	-63.50	--	-10,272.13
Net Margin (%)	-28.74	-216.73	-10,151.64
Cash Profit Margin (%)	0.00	--	-0.04

Growth Ratios

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Revenue Growth (%)	-45.93	0.10	-49.59
EBIT Growth (%)	63.51	--	36.61
Net Profit Growth (%)	85.07	14.39	35.11
EPS Growth (%)	84.53	0.36	--
Book Value Growth (%)	146.95	--	--

Valuation Ratios

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Price / Earnings	-2.47	-1.01	--
Price / Book Value	4.76	0.86	--
Dividend Yield (%)	--	--	--
EV/EBITDA	14.51	-1.26	0.81
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Debt to Equity	0.00	1.01	0.00
Short term debt to equity ratio	0.37	0.05	1.42
Current Ratio	1.56	3.98	0.72
Quick Ratio	1.56	3.75	0.72
Interest Coverage	-51.74	-25.45	-2,475.60

Operating Efficiency Ratios

	Molecular Templates (MTEM)	2seventy bio (TSVT)	Organovo Holdings (ONVO)
Debtors to sales (%)	3.12	13.36	21.31
Asset Turnover	0.53	0.16	0.01
Receivable days	1.59	62.53	75.02
Inventory Days	--	294.44	0.00
Payable days	53.56	142.88	464.98
Cash Conversion Cycle	--	214.09	-389.95

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.

Annual
Quarterly